Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study

Detalhes bibliográficos
Autor(a) principal: Oliveira, Arão Belitardo
Data de Publicação: 2024
Outros Autores: Barbosa Jr., Fernando, Santos, Itamar, Peres, Mario Fernando Prieto, Lotufo, Paulo, Benseñor, Isabela, Goulart, Alessandra
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Headache Medicine (Online)
Texto Completo: https://headachemedicine.com.br/index.php/hm/article/view/1267
Resumo: Background: Migraine disorders are thought to be influenced by a myriad of endogenous and environmental factors, including its association with metals/metalloid levels. However, this intricate relationship has never been comprehensively studied. Objective: We aimed to examine the risk of migraine disorders associated with serum levels of 16 metals/metalloids in the ELSA-Brasil study. Methods: This is a prospective analysis based on the serum levels of metals/metalloids in the baseline wave (2008-2010) and the migraine diagnosis in the inter-wave (2012-2014). Metals quantification was performed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and migraine diagnosis was based on ICHD-3, grouped as migraine without aura (MWO), migraine with aura (MWA), and non-migraine headache (NO). Modified Poisson regression models estimated the risk ratios (RR) with [95% confidence interval] for migraine diagnosis, according to metals concentration quintiles (Q), with the median as reference and 1st and 5th quintiles representing the lowest and highest metal levels, respectively. The adjusted models controlled for sex. age, education, race, smoking, alcohol intake, migraine prophylactic medication, and cardiometabolic risk factors. Results: The study included 2,662 adults, with a median (IQR) age: of 51 (45, 58) years and 52.7.0% (n = 1,403) female. In the adjusted models, 5th Q of Cu (RR: .79 [.64, .97]) and 3rd Q of Ba (RR: .86 [.76, .96]) were associated with a lower risk of NO, while 5th Q of Pb (RR: 1.16 [1.00, 1.34]) were associated with a higher risk of NO. The 1st Q of Fe (RR: 1.31 [1.01, 1.69]), 3rd Q of Ba (RR: 1.39 [1.14, 1.70]), and the 5th Q of Cd (RR: 1.35 [1.05, 1.74]) were associated with higher risk of MWO, while 5th Q of Se (RR: .70 [.50, .99]) and 3rd Q of Zn (RR: .78 [.63, .97]) were associated with lower risk of MWO. The extreme levels of Cd and Sr (5th Q and 1st Q) were associated with increased risk of MWA (RR: 1.48 [1.04, 2.10] and RR: 1.41 [1.01, 1.97], respectively). Finally, the 1st Q of Cu was associated with a lower risk of MWA (RR: .65 [.44, .97]). Conclusion: In the ELSA-Brasil, a diverse relationship was observed between metals and headaches with a higher magnitude of associations noticed with higher levels of Cd and both migraine subtypes.
id SBC_a5aa2d47443f2d5de48526bc3907fa7c
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1267
network_acronym_str SBC
network_name_str Revista Headache Medicine (Online)
repository_id_str
spelling Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil studyMigraineMetalsMetalloidsSeleniumCadmiumIronBackground: Migraine disorders are thought to be influenced by a myriad of endogenous and environmental factors, including its association with metals/metalloid levels. However, this intricate relationship has never been comprehensively studied. Objective: We aimed to examine the risk of migraine disorders associated with serum levels of 16 metals/metalloids in the ELSA-Brasil study. Methods: This is a prospective analysis based on the serum levels of metals/metalloids in the baseline wave (2008-2010) and the migraine diagnosis in the inter-wave (2012-2014). Metals quantification was performed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and migraine diagnosis was based on ICHD-3, grouped as migraine without aura (MWO), migraine with aura (MWA), and non-migraine headache (NO). Modified Poisson regression models estimated the risk ratios (RR) with [95% confidence interval] for migraine diagnosis, according to metals concentration quintiles (Q), with the median as reference and 1st and 5th quintiles representing the lowest and highest metal levels, respectively. The adjusted models controlled for sex. age, education, race, smoking, alcohol intake, migraine prophylactic medication, and cardiometabolic risk factors. Results: The study included 2,662 adults, with a median (IQR) age: of 51 (45, 58) years and 52.7.0% (n = 1,403) female. In the adjusted models, 5th Q of Cu (RR: .79 [.64, .97]) and 3rd Q of Ba (RR: .86 [.76, .96]) were associated with a lower risk of NO, while 5th Q of Pb (RR: 1.16 [1.00, 1.34]) were associated with a higher risk of NO. The 1st Q of Fe (RR: 1.31 [1.01, 1.69]), 3rd Q of Ba (RR: 1.39 [1.14, 1.70]), and the 5th Q of Cd (RR: 1.35 [1.05, 1.74]) were associated with higher risk of MWO, while 5th Q of Se (RR: .70 [.50, .99]) and 3rd Q of Zn (RR: .78 [.63, .97]) were associated with lower risk of MWO. The extreme levels of Cd and Sr (5th Q and 1st Q) were associated with increased risk of MWA (RR: 1.48 [1.04, 2.10] and RR: 1.41 [1.01, 1.97], respectively). Finally, the 1st Q of Cu was associated with a lower risk of MWA (RR: .65 [.44, .97]). Conclusion: In the ELSA-Brasil, a diverse relationship was observed between metals and headaches with a higher magnitude of associations noticed with higher levels of Cd and both migraine subtypes.Sociedade Brasileira de Cefaleia2024-08-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://headachemedicine.com.br/index.php/hm/article/view/1267Headache Medicine; Volume 15 - Supplement (2024): Abstracts from the Congresso Cefaleia 2024; 125Headache Medicine; Volume 15 - Suplemento (2024): Resumos do Congresso Cefaleia 2024; 1252763-6178reponame:Revista Headache Medicine (Online)instname:Sociedade Brasileira de Cefaleiainstacron:SBCenghttps://headachemedicine.com.br/index.php/hm/article/view/1267/1793Copyright (c) 2024 Arão Belitardo Oliveira, Fernando Barbosa Jr., Itamar Santos, Mario Fernando Prieto Peres, Paulo Lotufo, Isabela Benseñor, Alessandra Goulart (Author)https://creativecommons.org/licenses/by/4.0/deed.ptinfo:eu-repo/semantics/openAccessOliveira, Arão BelitardoBarbosa Jr., FernandoSantos, ItamarPeres, Mario Fernando PrietoLotufo, PauloBenseñor, IsabelaGoulart, Alessandra2024-10-01T01:01:09Zoai:ojs.pkp.sfu.ca:article/1267Revistahttp://headachemedicine.com.brPRIhttps://headachemedicine.com.br/index.php/hm/oaimmvalenca@yahoo.com.br | support@headachemedicine.com.br2763-61782178-7468opendoar:2024-10-01T01:01:09Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleiafalse
dc.title.none.fl_str_mv Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
title Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
spellingShingle Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
Oliveira, Arão Belitardo
Migraine
Metals
Metalloids
Selenium
Cadmium
Iron
title_short Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
title_full Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
title_fullStr Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
title_full_unstemmed Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
title_sort Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
author Oliveira, Arão Belitardo
author_facet Oliveira, Arão Belitardo
Barbosa Jr., Fernando
Santos, Itamar
Peres, Mario Fernando Prieto
Lotufo, Paulo
Benseñor, Isabela
Goulart, Alessandra
author_role author
author2 Barbosa Jr., Fernando
Santos, Itamar
Peres, Mario Fernando Prieto
Lotufo, Paulo
Benseñor, Isabela
Goulart, Alessandra
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Arão Belitardo
Barbosa Jr., Fernando
Santos, Itamar
Peres, Mario Fernando Prieto
Lotufo, Paulo
Benseñor, Isabela
Goulart, Alessandra
dc.subject.por.fl_str_mv Migraine
Metals
Metalloids
Selenium
Cadmium
Iron
topic Migraine
Metals
Metalloids
Selenium
Cadmium
Iron
description Background: Migraine disorders are thought to be influenced by a myriad of endogenous and environmental factors, including its association with metals/metalloid levels. However, this intricate relationship has never been comprehensively studied. Objective: We aimed to examine the risk of migraine disorders associated with serum levels of 16 metals/metalloids in the ELSA-Brasil study. Methods: This is a prospective analysis based on the serum levels of metals/metalloids in the baseline wave (2008-2010) and the migraine diagnosis in the inter-wave (2012-2014). Metals quantification was performed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and migraine diagnosis was based on ICHD-3, grouped as migraine without aura (MWO), migraine with aura (MWA), and non-migraine headache (NO). Modified Poisson regression models estimated the risk ratios (RR) with [95% confidence interval] for migraine diagnosis, according to metals concentration quintiles (Q), with the median as reference and 1st and 5th quintiles representing the lowest and highest metal levels, respectively. The adjusted models controlled for sex. age, education, race, smoking, alcohol intake, migraine prophylactic medication, and cardiometabolic risk factors. Results: The study included 2,662 adults, with a median (IQR) age: of 51 (45, 58) years and 52.7.0% (n = 1,403) female. In the adjusted models, 5th Q of Cu (RR: .79 [.64, .97]) and 3rd Q of Ba (RR: .86 [.76, .96]) were associated with a lower risk of NO, while 5th Q of Pb (RR: 1.16 [1.00, 1.34]) were associated with a higher risk of NO. The 1st Q of Fe (RR: 1.31 [1.01, 1.69]), 3rd Q of Ba (RR: 1.39 [1.14, 1.70]), and the 5th Q of Cd (RR: 1.35 [1.05, 1.74]) were associated with higher risk of MWO, while 5th Q of Se (RR: .70 [.50, .99]) and 3rd Q of Zn (RR: .78 [.63, .97]) were associated with lower risk of MWO. The extreme levels of Cd and Sr (5th Q and 1st Q) were associated with increased risk of MWA (RR: 1.48 [1.04, 2.10] and RR: 1.41 [1.01, 1.97], respectively). Finally, the 1st Q of Cu was associated with a lower risk of MWA (RR: .65 [.44, .97]). Conclusion: In the ELSA-Brasil, a diverse relationship was observed between metals and headaches with a higher magnitude of associations noticed with higher levels of Cd and both migraine subtypes.
publishDate 2024
dc.date.none.fl_str_mv 2024-08-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://headachemedicine.com.br/index.php/hm/article/view/1267
url https://headachemedicine.com.br/index.php/hm/article/view/1267
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://headachemedicine.com.br/index.php/hm/article/view/1267/1793
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0/deed.pt
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/deed.pt
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cefaleia
publisher.none.fl_str_mv Sociedade Brasileira de Cefaleia
dc.source.none.fl_str_mv Headache Medicine; Volume 15 - Supplement (2024): Abstracts from the Congresso Cefaleia 2024; 125
Headache Medicine; Volume 15 - Suplemento (2024): Resumos do Congresso Cefaleia 2024; 125
2763-6178
reponame:Revista Headache Medicine (Online)
instname:Sociedade Brasileira de Cefaleia
instacron:SBC
instname_str Sociedade Brasileira de Cefaleia
instacron_str SBC
institution SBC
reponame_str Revista Headache Medicine (Online)
collection Revista Headache Medicine (Online)
repository.name.fl_str_mv Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleia
repository.mail.fl_str_mv mmvalenca@yahoo.com.br | support@headachemedicine.com.br
_version_ 1838629562868563968